Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DNA – Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc.
DNA
$14.93
Name : Ginkgo Bioworks Holdings, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $883,852,288.00
EPSttm : -5.76
finviz dynamic chart for DNA
Ginkgo Bioworks Holdings, Inc.
$14.93
0.40%
$0.06

Float Short %

15.48

Margin Of Safety %

Put/Call OI Ratio

0.09

EPS Next Q Diff

-0.17

EPS Last/This Y

5.29

EPS This/Next Y

0.91

Price

14.86

Target Price

11.33

Analyst Recom

3.75

Performance Q

33.6

Relative Volume

1.08

Beta

1.54

Ticker: DNA




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08DNA11.190.160.16113057
2025-09-09DNA10.760.160.16113340
2025-09-10DNA10.280.160.41113266
2025-09-11DNA10.440.150.09112981
2025-09-12DNA100.160.49112279
2025-09-15DNA10.210.160.15114343
2025-09-16DNA10.610.160.51114592
2025-09-17DNA11.070.163079478583220.078421052631579114832
2025-09-18DNA11.420.160.09115013
2025-09-19DNA11.380.160.60114530
2025-09-22DNA12.020.080.1197369
2025-09-23DNA12.330.090.2298832
2025-09-24DNA11.540.090.2399634
2025-09-25DNA11.250.090.2899899
2025-09-26DNA11.490.090.09100261
2025-09-29DNA13.040.090.14100369
2025-09-30DNA14.580.090.05101307
2025-10-01DNA14.670.090.07105170
2025-10-02DNA15.960.090.11105496
2025-10-03DNA16.120.090.16107273
2025-10-06DNA14.880.090.16107497
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08DNA11.19- - -5.25
2025-09-09DNA10.76- - -5.25
2025-09-10DNA10.27- - -5.25
2025-09-11DNA10.44- - -5.25
2025-09-12DNA9.99- - -5.25
2025-09-15DNA10.26- - -5.25
2025-09-16DNA10.63- - -5.25
2025-09-17DNA11.09- - -5.25
2025-09-18DNA11.43- - -5.25
2025-09-19DNA11.35- - -5.25
2025-09-22DNA12.03- - -5.25
2025-09-23DNA12.34- - -5.25
2025-09-24DNA11.54- - -5.25
2025-09-25DNA11.25- - -5.25
2025-09-26DNA11.50- - -5.25
2025-09-29DNA13.23- - -5.25
2025-09-30DNA14.60- - -5.25
2025-10-01DNA14.68- - -5.25
2025-10-02DNA15.94- - -5.25
2025-10-03DNA16.15- - -5.25
2025-10-06DNA14.86- - -5.25
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08DNA-0.033.3317.53
2025-09-09DNA-0.033.3317.53
2025-09-10DNA-0.153.3317.53
2025-09-11DNA-0.153.3316.56
2025-09-12DNA-0.153.3316.56
2025-09-15DNA-0.163.3216.56
2025-09-16DNA-0.163.3216.56
2025-09-17DNA-0.153.3216.56
2025-09-18DNA-0.153.3216.56
2025-09-19DNA-0.153.3216.56
2025-09-22DNA-0.153.3316.56
2025-09-23DNA-0.153.3316.56
2025-09-24DNA-0.153.3316.56
2025-09-25DNA-0.153.3315.48
2025-09-26DNA-0.153.3315.48
2025-09-29DNA-0.153.3415.48
2025-09-30DNA-0.153.3415.48
2025-10-01DNA-0.153.3415.48
2025-10-02DNA-0.153.3415.48
2025-10-03DNA-0.183.3415.48
2025-10-06DNA-0.182.6415.48
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-1.1

Avg. EPS Est. Current Quarter

-1.24

Avg. EPS Est. Next Quarter

-1.27

Insider Transactions

-0.18

Institutional Transactions

2.64

Beta

1.54

Average Sales Estimate Current Quarter

38

Average Sales Estimate Next Quarter

40

Fair Value

Quality Score

29

Growth Score

33

Sentiment Score

79

Actual DrawDown %

97.7

Max Drawdown 5-Year %

Target Price

11.33

P/E

Forward P/E

PEG

P/S

3.81

P/B

1.27

P/Free Cash Flow

EPS

-5.85

Average EPS Est. Cur. Y​

-5.25

EPS Next Y. (Est.)

-4.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-136.56

Relative Volume

1.08

Return on Equity vs Sector %

-76.5

Return on Equity vs Industry %

-62.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.87

EBIT Estimation

Ginkgo Bioworks Holdings, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 834
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
stock quote shares DNA – Ginkgo Bioworks Holdings, Inc. Stock Price stock today
news today DNA – Ginkgo Bioworks Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DNA – Ginkgo Bioworks Holdings, Inc. yahoo finance google finance
stock history DNA – Ginkgo Bioworks Holdings, Inc. invest stock market
stock prices DNA premarket after hours
ticker DNA fair value insiders trading